Calidi Biotherapeutics, Inc. (NYSE:CLDI) is held by 27 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 879,000 | 879,000 | 0.00% | $209,905.00 |
| SABBY MANAGEMENT, LLC | 31 Mar, 2026 | 434,903 | 434,903 | 0.00% | $103,855.00 |
| Warberg Asset Management LLC | 31 Mar, 2026 | 250,000 | 250,000 | 0.00% | $59,475.00 |
| DRW Securities, LLC | 31 Mar, 2026 | 147,767 | 147,767 | 0.00% | $172,887.00 |
| HighTower Advisors, LLC | 31 Mar, 2026 | 83,523 | -1,433 | -1.69% | $97,722.00 |
| HighTower Advisors, LLC | 31 Mar, 2026 | 83,523 | 0 | 0.00% | $19,945.00 |
| Virtu Financial LLC | 31 Mar, 2026 | 75,769 | 54,526 | 256.68% | $18.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 63,019 | 21,090 | 50.30% | $15,048.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 41,929 | 12,334 | 41.68% | $49,056.00 |
| Arax Advisory Partners | 31 Mar, 2026 | 37,345 | 37,345 | 0.00% | $8,918.00 |
| JANE STREET GROUP, LLC | 31 Mar, 2026 | 34,802 | 23,311 | 202.86% | $8,311.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 34,728 | 0 | 0.00% | $40,632.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 25,509 | 25,509 | 0.00% | $6,097.00 |
| FMR LLC | 31 Mar, 2026 | 22,013 | 21,888 | 17,510.40% | $25,755.00 |
| Virtu Financial LLC | 31 Mar, 2026 | 21,243 | 21,243 | 0.00% | $25.00 |
| RS CRUM INC. | 31 Mar, 2026 | 20,256 | 5,000 | 32.77% | $23,700.00 |
| Belpointe Asset Management LLC | 31 Mar, 2026 | 19,971 | -850 | -4.08% | $23,366.00 |
| Belpointe Asset Management LLC | 31 Mar, 2026 | 19,921 | -50 | -0.25% | $4,757.00 |
| Northern Trust Corp | 31 Mar, 2026 | 17,758 | 17,758 | 0.00% | $20,777.00 |
| Northern Trust Corp | 31 Mar, 2026 | 17,758 | 0 | 0.00% | $4,241.00 |